Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system

被引:44
作者
Shomaker, TS [1 ]
Zhang, J [1 ]
Ashburn, MA [1 ]
机构
[1] Univ Utah, Sch Med, Dept Anesthesiol, Off Dean, Salt Lake City, UT 84132 USA
关键词
opioid analgesic; fentanyl; transdermal drug delivery; cancer pain;
D O I
10.1046/j.1526-4637.2000.00030.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives. To examine the effects of locally applied heat on the systemic delivery of fentanyl through the Transdermal Fentanyl Delivery System. Design. Open, 2-period crossover randomized study conducted in the anesthesia department of a university teaching hospital. Method. Six healthy adult volunteers received a fentanyl 25-mug/h patch with and without local heat for 240 minutes followed by administration without heat for an additional 20 hours. Participants then crossed over. Venous blood was drawn at baseline and hourly for 24 hours. Peak plasma concentration (CMax) of fentanyl was measured and the area under the curve (AUC) of the plasma fentanyl concentration versus time post administration graph was evaluated. Results. Difference in CMax and AUC were not statistically significant over the entire 24-hour study period. However, for the 4-hour period of heat application statistically significant differences were seen in both mean CMax (heat, 0.4 ng/mL versus no heat, 0.1 ng/mL (P =.030)) and mean AUC (heat, 10 ng/mL min versus no heat, 10 ng/mL min (P =.010)). Conclusion. Local heat can speed the onset of steady state fentanyl concentration in the Fentanyl Transdermal Drug Delivery System(TM) thus limiting the delay in onset of analgesia and allowing earlier identification and treatment of side effects.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 21 条
[11]   Clinical pharmacokinetics of transdermal opioids - Focus on transdermal fentanyl [J].
Grond, S ;
Radbruch, L ;
Lehmann, KA .
CLINICAL PHARMACOKINETICS, 2000, 38 (01) :59-89
[12]   POSTOPERATIVE ANALGESIA WITH FENTANYL - PHARMACOKINETICS AND PHARMACODYNAMICS OF CONSTANT-RATE IV AND TRANSDERMAL DELIVERY [J].
HOLLEY, FO ;
VANSTEENNIS, C .
BRITISH JOURNAL OF ANAESTHESIA, 1988, 60 (06) :608-613
[13]   ORAL TRANSMUCOSAL FENTANYL CITRATE FOR ANALGESIA AND SEDATION IN THE EMERGENCY DEPARTMENT [J].
LIND, GH ;
MARCUS, MA ;
MEARS, SL ;
ASHBURN, MA ;
PETERSON, BJ ;
BERNHISEL, KT ;
STANLEY, TH .
ANNALS OF EMERGENCY MEDICINE, 1991, 20 (10) :1117-1120
[14]  
PLEZIA PM, 1989, PHARMACOTHERAPY, V9, P2
[15]   TRANSDERMAL FENTANYL FOR CANCER PAIN - REPEATED DOSE PHARMACOKINETICS [J].
PORTENOY, RK ;
SOUTHAM, MA ;
GUPTA, SK ;
LAPIN, J ;
LAYMAN, M ;
INTURRISI, CE ;
FOLEY, KM .
ANESTHESIOLOGY, 1993, 78 (01) :36-43
[16]  
READY LB, 1988, ANESTHESIOLOGY, V69, P139, DOI 10.1097/00000542-198807000-00029
[17]   FENTANYL TRANSDERMAL SYSTEM OVERDOSE SECONDARY TO CUTANEOUS HYPERTHERMIA [J].
ROSE, PG ;
MACFEE, MS ;
BOSWELL, MV .
ANESTHESIA AND ANALGESIA, 1993, 77 (02) :390-391
[18]  
SHOMAKER TS, IN PRESS CLIN J PAIN
[19]   NOVEL DELIVERY SYSTEMS - ORAL TRANSMUCOSAL AND INTRANASAL TRANSMUCOSAL [J].
STANLEY, TH ;
ASHBURN, MA .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (03) :163-171
[20]  
STANLEY TH, 1988, ANESTHESIOLOGY, V68, P665